Trials / Completed
CompletedNCT04353401
WGS Analysis of COVID-19 Positive Patients
Whole Genome Sequencing Analysis of of SARS-CoV-2 Positive Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.
Conditions
Timeline
- Start date
- 2020-08-03
- Primary completion
- 2022-03-09
- Completion
- 2022-03-09
- First posted
- 2020-04-20
- Last updated
- 2024-03-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04353401. Inclusion in this directory is not an endorsement.